Examinations of the bactericidal properties of the serum against gram-positive microbes in patients suffering from leukaemia, malignant lymphoma, myeloma and myelofibrosis.
D001407:Bacillus / Q000187:drug effects*; D001769:Blood; D001770:Blood Bactericidal Activity; D006689:Hodgkin Disease / Q000276:immunology*; D006801:Humans; D007109:Immunity; D066298:In Vitro Techniques; D007938:Leukemia / Q000276:immunology*; D007945:Leukemia, Lymphoid / Q000276:immunology*; D007951:Leukemia, Myeloid / Q000276:immunology*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000276:immunology*; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology*; D009101:Multiple Myeloma / Q000276:immunology*; D055728:Primary Myelofibrosis / Q000276:immunology*